Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Subscribe Now!

Related Content

Improving patient financial experience: A strategic imperative

ByLaxmi Patel

December 5th 2025

In defense of private equity, with Jared Rhoads, M.S., M.P.H., of the Center for Modern Health

ByAustin Littrell

December 4th 2025

Health care M&A in motion: Regulation, strategy and investor focus

ByClint Bundy,Stewart Carlin

November 24th 2025

The financial case for direct contracting partnerships: Why health systems can’t afford to wait

ByJack Hill

November 7th 2025

Better together: Why primary care wins when physicians, payers and pharma share data

ByErrol Rodericks

November 6th 2025

Latest CME

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Entertaining patient wait times

Articles in this issue

Newsletter

Related Content

Improving patient financial experience: A strategic imperative

In defense of private equity, with Jared Rhoads, M.S., M.P.H., of the Center for Modern Health

Health care M&A in motion: Regulation, strategy and investor focus

The financial case for direct contracting partnerships: Why health systems can’t afford to wait

Better together: Why primary care wins when physicians, payers and pharma share data

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

Protected EHR time cuts after-hours work with little productivity loss, study finds

Epic monopoly on EHRs is hurting U.S. health care, Texas AG says

Point-of-care testing, with Daniel Krajcik, D.O., MBA

Building a bank for doctors: The origins of Panacea Financial

What's new in the American Diabetes Association's 2026 diabetes care standards